FDA Inspection 1331920 — Natco Pharma Limited

Natco Pharma Limited — FEI 3015380536

The FDA completed an inspection of Natco Pharma Limited on Aug 21, 2026 in Anakapalli. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 21, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Anakapalli (India)

Citations

IDCFRDescription
122221 CFR 211.67(b)(4)Cleaning SOPs/equipment identification
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
184221 CFR 211.84(d)(1)Component identity verification
354721 CFR 211.46(b)Equipment for Environmental Control

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.